CT-FASTSimulation support to leansupplychainmanagementCédric Druckcedric.druck@n-side.com+32 497 31 84 69www.ct-fast.com
OutlineIntroduction to clinical trialsThe ChallengeSimulation & optimization
OutlineIntroduction to clinical trialsThe ChallengeSimulation & optimization
Drug DevelopmentDrugDiscovery(5,000-10,000)Lab, animal testingPreClinicalDevelopment(250)First Human DoseClinicalResearch(5)$550MNDA$350MTo market (1) : 10 years
Clinical Trial DesignGLOBAL ENROLLMENT	Target number of Patients	Investigation Sites	Countries	Label GroupsSTRATIFICATIONDifferentclasses of patientsBLINDINGTreatmentassignmentisundisclosedRANDOMIZATIONRandomtreatmentassignmente.g. Active/Placebo/ComparatorAABAA?????B?BB??
Visits and TreatmentVISIT SCHEDULEPatient returnsat a defined (flexible) scheduleTITRATIONSDosage may change based on events / doctor opinion / …
Supply ChainWHAT?Specific (expensive) Kit Types	Limited shelf life(potential extension)	Limited availabilityDifferent Labels / bookletsHOW?	Shipping strictlydownstream, long lead times, sometimes cold-chain
OutlineIntroduction to clinical trialsThe ChallengeSimulation & optimization
Do it Right7!Don’t let us down!DRASTIC SERVICE LEVELS DEMANDEDPatients healthatstake!
The rest of the trouble makers…
DealingwithuncertaintyForecasting, simulation, what-if analysis plan, implement, control
reduce the costs of the othertwo
maintain a high service levelProduction / safety stocksPotentiallyexpensiveJust-in-time: frequentsmallshipmentsPotentiallyexpensive
Do itJUST right7!LEANBalance riskand the differentcosts to effectivelyachieve a high service level
OutlineIntroduction to clinical trialsThe ChallengeSimulation & optimization
Benefits
Simulation PrinciplesINTEGRATED MONTE-CARLOEnroll & treat patients – learning setComputeinventory managementstrategiesDistribute kits & match thedemand – validation setEstimate performanceindicatorsWHAT-IF ANALYSISCompare differentstudy designsVerifyrobustnesswith regards to assumptionsREAL-LIFE DATA TOInitializethe simulationsBalance the user assumptions
Leveragingactual dataINITIALIZE – Using a snapshot of the trial (patients, inventories…)New batchCurrent stock62 kits51 kitsData estimateWEIGHData
AssumptionsBased onAmount of data
User confidenceUser estimate
CT-FAST Process
Cost vs. Risk: Case studyProcessimprovement suggestionsSupplystrategyoptimization

CT simulation & optimization

Editor's Notes

  • #3 4. Simulationprinciples – integrated, demand/supply/network. Based on assumptions, distributions and randomevents, real-life dataWhen to use it and howEarlyInitialAfterstudystartReacting to change
  • #4 4. Simulationprinciples – integrated, demand/supply/network. Based on assumptions, distributions and randomevents, real-life dataWhen to use it and howEarlyInitialAfterstudystartReacting to change
  • #5 New Drug Application (NDA)EMA = EuropeanMedicinesAgency
  • #9 4. Simulationprinciples – integrated, demand/supply/network. Based on assumptions, distributions and randomevents, real-life dataWhen to use it and howEarlyInitialAfterstudystartReacting to change
  • #14 4. Simulationprinciples – integrated, demand/supply/network. Based on assumptions, distributions and randomevents, real-life dataWhen to use it and howEarlyInitialAfterstudystartReacting to change